On March 4, 2024, NewGLAB Pharma CO.,LTD closed the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6,915 KRW | -27.44% | -.--% | -.--% |
1st Jan change | Capi. | |
---|---|---|
-.--% | 46.5M | |
+3.95% | 387B | |
-3.34% | 1.58B | |
+151.25% | 1.21B | |
-10.43% | 1.19B | |
+25.11% | 929M | |
-18.43% | 695M | |
+47.35% | 684M | |
+0.87% | 339M | |
-34.93% | 335M |
- Stock Market
- Equities
- A214870 Stock
- News NewGLAB Pharma CO.,LTD
- NewGLAB Pharma CO.,LTD announced that it has received KRW 6.835 billion in funding from Namhwa Corporation, SLP Co. Ltd. and other investors